Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroblastoma × Dacarbazine × 30 days × Clear all

Sponsor

Conditions

Hodgkin Disease 4 Melanoma 2 Uveal Melanoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplasms 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leiomyosarcoma 1 Advanced Melanoma 1

Interventions

dinutuximab 6 Biopsy 5 sargramostim 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Eflornithine 4 Cyclophosphamide 4 Colony-Stimulating Factors 4 X-Rays 3 Temozolomide 3 Phantoms, Imaging 3 Isotretinoin 3 Irinotecan 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 saponin QA-21V1 2 naxitamab 2 etoposide phosphate 2 ceritinib 2 Vincristine 2 Topotecan 2 Nuclear Medicine Department, Hospital 2 Melphalan 2 3-Iodobenzylguanidine 2 tipifarnib 1 silmitasertib 1 ribociclib 1 lorlatinib 1 iberdomide 1 fludarabine 1 erdafitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡